切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2017, Vol. 06 ›› Issue (03) : 238 -242. doi: 10.3877/cma.j.issn.2095-3224.2017.03.014

所属专题: 文献

综述

大肠癌肝转移治疗进展
李奕1, 邰升1,()   
  1. 1. 150086 哈尔滨医科大学附属第二医院胆胰外科
  • 收稿日期:2017-01-22 出版日期:2017-06-25
  • 通信作者: 邰升

Progression of treatments for colorectal liver metastasis

Yi Li1, Sheng Tai1,()   

  1. 1. Department of Biliary-Pancreatic Surgery, Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China
  • Received:2017-01-22 Published:2017-06-25
  • Corresponding author: Sheng Tai
  • About author:
    Corresponding author: Tai Sheng, Email:
引用本文:

李奕, 邰升. 大肠癌肝转移治疗进展[J/OL]. 中华结直肠疾病电子杂志, 2017, 06(03): 238-242.

Yi Li, Sheng Tai. Progression of treatments for colorectal liver metastasis[J/OL]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2017, 06(03): 238-242.

肝脏是大肠癌远处转移最为常见的器官之一,正确有效的肝转移治疗不但延缓疾病进程,延长患者寿命,同时也能为患者的预后质量提供良好保障。目前外科手术切除治疗仍是大肠癌肝转移的首选,随着相关技术的不断发展以及人们对大肠癌肝转移研究的不断深入,放射疗法、冷冻疗法、射频消融术等新型治疗手段也在不断得以实践,多学科综合治疗将为大肠癌肝转移的临床治疗提供新的研究方向。

Liver is one of the most common organs for colorectal cancer distant metastasis, a correct and effective treatment applied in the regulation of liver metastasis could not only delay of disease progression but also extend the survival time, at the same time providing a better guarantee for the prognosis of patients with quality. Up to now, surgical resection still counts for the first selection for colorectal liver metastasis. With the continuous development of related technologies and the deep insights into this malignant biological behavior, new treatments are able to be practiced constantly, including radiotherapy, cryotherapy, radiofrequency and other approaches. Thus, multidisciplinary synthetic therapy will designate research direction for the treatment of colorectal liver metastasis.

[1]
中华医学会外科学分会胃肠外科学组. 结直肠癌肝转移诊断和综合治疗指南(2016版) [J]. 中华消化外科杂志, 2016, 15(8):755-767.
[2]
Esfahani S, Heidari P, Sheth R, et al. Non-invasive imaging of C-MET receptor for delineation of liver metastasis of colorectal cancer [J]. Journal of Nuclear Medicine, 2013, 54(2):300-305.
[3]
中国抗癌协会大肠癌专业委员会专家组. 结直肠癌肝转移转化治疗中靶向药物合理应用的专家指导意见 [J]. 中华胃肠外科杂志, 2013, 16(10):1000-1004.
[4]
林俊忠, 潘志忠. 结直肠癌肝转移外科治疗的争议 [J]. 中华胃肠外科杂志, 2013, 16(8):714-717.
[5]
邢宝才. 结直肠癌肝转移的规范化治疗 [J]. 中华消化外科杂志, 2013, 12(6):413-416.
[6]
Ter Voert EG, Heijmen L, de Wilt JH, et al. Reproducibility and biological basis of in vivo T(2)* magnetic resonance imaging of liver metastasis of colorectal cancer [J]. Magnetic Resonance in Medicine, 2013, 70(4):1145–1152.
[7]
孙谊, 闫晓峦, 王崑, 等. 结直肠癌多发性肝转移手术切除的疗效 [J]. 中华肝胆外科杂志, 2014, 20(3):195-200.
[8]
刘德军, 陈炜, 张斌, 等. 结直肠癌同时性肝转移手术时机的选择 [J]. 中华消化外科杂志, 2012, 11(3):294-295.
[9]
胡俊杰, 周志祥, 梁建伟, 等. 结直肠癌同时性肝转移同期手术切除疗效分析 [J]. 中华肿瘤杂志, 2013, 35(1):63-66.
[10]
盛勤松, 林才照, 严盛, 等. 手助腹腔镜结直肠癌肝转移一期同步切除术六例分析 [J]. 中华普通外科杂志, 2012, 27(12):982-984.
[11]
周进学, 王凯, 李庆军, 等. 腹腔镜结直肠癌肝转移一期切除术的临床疗效 [J]. 中华消化外科杂志, 2016, 15(2):135-139.
[12]
Chen Dong-liang, Wang Zhi-qiang, Zeng Zhao-lei, et al. Identification of MicroRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression [J]. Hepatology, 2014, 60(2):598–609.
[13]
Yuge R, Kitadai Y, Shinagawa K, et al. mTOR and PDGF pathway blockade inhibits liver metastasis of colorectal cancer by modulating the tumor microenvironment [J]. American Journal of Pathology, 2015, 185(2):399-408.
[14]
朱德祥, 任黎, 许剑民. 伴有同时性不可切除肝转移的结直肠癌患者治疗的思考 [J]. 中华胃肠外科杂志, 2013, 16(8):718-720.
[15]
Weidle UH, Birzele F, Krüger A. Molecular targets and pathways involved in liver metastasis of colorectal cancer [J]. Clinical & Experimental Metastasis, 2015, 32(6):623-635.
[16]
Kee JY, Ito A, Hojo S, et al. Chemokine CXCL16 suppresses liver metastasis of colorectal cancer via augmentation of tumor-infiltrating natural killer T cells in a murine model [J]. Oncology Reports, 2013, 29(3):975-982.
[17]
王杉, 申占龙. 对我国结直肠癌肝转移治疗现状的思考 [J]. 中华胃肠外科杂志, 2012, 15(10):993-996.
[18]
Enquist IB, Good Z, Jubb AM, et al. Lymph node-independent liver metastasis in a model of metastatic colorectal cancer [J]. Nature Communications, 2014, 5(5):3530.
[19]
Zhang Y, Davis C, Ryan J, et al. Development and characterization of a reliable mouse model of colorectal cancer metastasis to the liver [J]. Clinical & Experimental Metastasis, 2013, 30(7):903-904.
[20]
Lee HS, Kim HO, Hong YS, et al. Prognostic value of metabolic parameters in patients with synchronous colorectal cancer liver metastasis following curative-intent colorectal and hepatic surgery [J]. Journal of Nuclear Medicine, 2014, 55(4):582-529.
[21]
Ye LC, Ren L, Qiu JJ, et al. Aberrant expression of long noncoding RNAs in colorectal cancer with liver metastasis [J]. Tumor Biology, 2015, 36(11):1-8.
[22]
马宽生, 王青兵. 结直肠癌肝转移射频治疗的现状与进展 [J]. 中华消化外科杂志, 2016, 15(2):117-122.
[23]
Lee H, Choi DW, Cho YB, et al. Recurrence pattern depends on the location of colon cancer in the patients with synchronous colorectal liver metastasis [J]. Annals of Surgical Oncology, 2014, 21(5):1641-1646.
[24]
王青兵, 蒋家云, 谭运华, 等. 结直肠癌肝转移治疗10年随访:单中心120例分析 [J]. 中华肝胆外科杂志, 2015, 21(7):449-453.
[25]
赵明, 王健鹏, 吴沛宏. 射频消融治疗结直肠癌肝转移的现状 [J]. 中华肿瘤杂志, 2011, 33(6):401-404.
[26]
Maruyama T, Murata S, Nakayama K, et al. Epigallocatechin-3-gallate suppresses liver metastasis of human colorectal cancer [J]. Oncology Reports, 2013, 31(2):625-633.
[27]
Lin Q, Tan HT, Lim TK, et al. iTRAQ analysis of colorectal cancer cell lines suggests Drebrin (DBN1) is overexpressed during liver metastasis [J]. Proteomics, 2014, 14(11):1434-1443.
[28]
Chen H, Peng H, Liu W, et al. Silencing of plasminogen activator inhibitor-1 suppresses colorectal cancer progression and liver metastasis [J]. Surgery, 2015, 158(6):1704-1173.
[29]
孙志强, 陈健, 黄志成, 等. 介入热化疗栓塞联合125I粒子植入治疗大肠癌肝转移的临床观察 [J]. 中华放射医学与防护杂志, 2016, 36(4):294-297.
[30]
Nakayama N, Yamashita K, Tanaka T, et al. Genomic gain of the PRL-3 gene may represent poor prognosis of primary colorectal cancer, and associate with liver metastasis [J]. Clinical & Experimental Metastasis, 2016, 33(1):3-13.
[1] 罗青杉, 梅海涛, 郝家领, 蔡锦锋, 周润楷, 温玉刚. 连接蛋白43通过调控细胞周期抑制结直肠癌的增殖机制研究[J/OL]. 中华普通外科学文献(电子版), 2024, 18(05): 344-349.
[2] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[3] 杨建波, 马欢, 黄小梅, 刘华柱. 结肠镜辅助下EMR、CSP和RFA术治疗直径<1cm结直肠息肉的疗效和安全性比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 76-79.
[4] 臧宇, 姚胜, 朱新勇, 戎世捧, 田智超. 低温等离子射频消融治疗腹壁疝术后补片感染的临床效果[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 687-692.
[5] 张润锦, 阳盼, 林燕斯, 刘尊龙, 刘建平, 金小岩. EB病毒相关胆管癌伴多发转移一例及国内文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 865-869.
[6] 何慧玲, 鲁祖斌, 冯嘉莉, 梁声强. 术前外周血NLR和PLR对结肠癌术后肝转移的影响[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 682-687.
[7] 严虹霞, 王晓娟, 张毅勋. 2 型糖尿病对结直肠癌患者肿瘤标记物、临床病理及预后的影响[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 483-487.
[8] 赵磊, 刘文志, 林峰, 于剑, 孙铭骏, 崔佑刚, 张旭, 衣宇鹏, 于宝胜, 冯宁. 深部热疗在改善结直肠癌术后辅助化疗副反应及生活质量中的作用研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 488-493.
[9] 黄海洋, 邝永龙, 陈嘉胜. 基层医院结直肠肿瘤经自然腔道取标本手术30 例分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 510-518.
[10] 韩加刚, 王振军. 梗阻性左半结肠癌的治疗策略[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 450-458.
[11] 梁轩豪, 李小荣, 李亮, 林昌伟. 肠梗阻支架置入术联合新辅助化疗治疗结直肠癌急性肠梗阻的疗效及其预后的Meta 分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 472-482.
[12] 任佳琪, 刁德昌, 何自衍, 张雪阳, 唐新, 李文娟, 李洪明, 卢新泉, 易小江. 网膜融合线导向的脾曲游离技术在左半结肠癌根治术中的应用[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 362-367.
[13] 张迪, 王春霞, 张学东, 李发馨, 庞淅文, 陈一锋, 张维胜, 王涛. 梗阻性左半结直肠癌自膨式金属支架置入后行腹腔镜手术与开腹手术的短期临床疗效比较[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 375-380.
[14] 张蔚林, 王哲学, 白峻阁, 黄忠诚, 肖志刚. 利用TCGA数据库构建基于miRNA的结直肠癌列线图预后模型[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 381-388.
[15] 张伟伟, 陈启, 翁和语, 黄亮. 随机森林模型预测T1 期结直肠癌淋巴结转移的初步研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 389-393.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?